🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
565,72 USD
Máx. histórico
608,49
1 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,03%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-7,03%
Cierre anterior
608,49
Rango de hoy
561,24 – 608,04
Volumen hoy
602.001
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,36 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 14 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 27/09/2005 | 35,10 | 35,55 | 33,84 | 34,55 | -1,45% | 4,89% | 617.400 |
| 26/09/2005 | 35,03 | 35,29 | 34,43 | 35,06 | +0,67% | 2,44% | 362.000 |
| 23/09/2005 | 34,55 | 35,05 | 34,00 | 34,82 | +0,55% | 3,04% | 336.400 |
| 22/09/2005 | 34,20 | 34,80 | 33,29 | 34,63 | +0,89% | 4,42% | 558.000 |
| 21/09/2005 | 34,45 | 34,91 | 34,10 | 34,33 | -0,65% | 2,35% | 660.200 |
| 20/09/2005 | 35,70 | 35,70 | 34,47 | 34,55 | -1,51% | 3,43% | 463.600 |
| 19/09/2005 | 35,55 | 36,12 | 35,01 | 35,08 | -1,18% | 3,12% | 423.000 |
| 16/09/2005 | 35,68 | 35,78 | 35,10 | 35,50 | +0,00% | 1,91% | 515.400 |
| 15/09/2005 | 35,68 | 36,25 | 35,12 | 35,50 | -0,62% | 3,18% | 548.800 |
| 14/09/2005 | 36,40 | 36,49 | 35,55 | 35,72 | -1,52% | 2,58% | 562.200 |
| 13/09/2005 | 36,36 | 36,55 | 35,68 | 36,27 | -0,52% | 2,41% | 666.200 |
| 12/09/2005 | 37,13 | 37,41 | 36,25 | 36,46 | -1,33% | 3,11% | 764.600 |
| 09/09/2005 | 35,86 | 37,08 | 35,00 | 36,95 | +5,80% | 5,80% | 1.533.400 |
| 08/09/2005 | 35,71 | 36,25 | 34,63 | 34,93 | -2,24% | 4,54% | 832.000 |
| 07/09/2005 | 34,94 | 36,16 | 34,52 | 35,73 | +2,10% | 4,69% | 667.800 |
| 06/09/2005 | 34,64 | 35,30 | 34,35 | 34,99 | +1,23% | 2,74% | 513.600 |
| 02/09/2005 | 34,98 | 35,23 | 34,38 | 34,57 | -1,19% | 2,44% | 341.800 |
| 01/09/2005 | 35,11 | 35,73 | 34,51 | 34,98 | -0,36% | 3,49% | 808.200 |
| 31/08/2005 | 35,01 | 35,36 | 34,60 | 35,11 | +0,40% | 2,16% | 720.000 |
| 30/08/2005 | 34,87 | 35,42 | 34,33 | 34,97 | +0,09% | 3,14% | 740.800 |
| 29/08/2005 | 34,60 | 35,11 | 34,38 | 34,94 | +0,50% | 2,12% | 515.800 |
| 26/08/2005 | 35,39 | 35,49 | 34,30 | 34,76 | -1,74% | 3,36% | 624.800 |
| 25/08/2005 | 35,10 | 35,51 | 34,89 | 35,38 | +1,09% | 1,78% | 304.000 |
| 24/08/2005 | 35,09 | 35,76 | 34,63 | 35,00 | -0,74% | 3,21% | 544.800 |
| 23/08/2005 | 35,83 | 36,32 | 34,75 | 35,26 | -1,19% | 4,38% | 713.800 |
| 22/08/2005 | 35,27 | 36,07 | 34,91 | 35,68 | +2,09% | 3,29% | 1.125.600 |
| 19/08/2005 | 34,70 | 35,76 | 34,67 | 34,95 | +0,07% | 3,14% | 911.600 |
| 18/08/2005 | 34,75 | 35,47 | 34,36 | 34,93 | -0,01% | 3,18% | 1.025.200 |
| 17/08/2005 | 34,79 | 35,40 | 34,67 | 34,93 | +0,09% | 2,10% | 966.000 |
| 16/08/2005 | 34,15 | 35,75 | 34,03 | 34,90 | +1,90% | 5,05% | 3.392.800 |